Physician profile
Sunit Singhal
NPI 1043282163
$582.35
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.67 · 2020: $40.72 · 2021: $222 · 2022: $156 · 2023: $86.47 · 2024: $58.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $144.43 | 2019-2024 | Shingrix, Arexvy |
| Lumenis Be INC | $140.21 | 2021 | |
| Allergan, INC. | $58.85 | 2021-2022 | |
| Amarin Pharma, INC. | $58.38 | 2022 | |
| Novo Nordisk INC | $53.74 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Merz North America, INC. | $40.72 | 2020 | |
| Abbvie INC. | $32.23 | 2023 | Vraylar |
| Pfizer INC. | $24.84 | 2022 | |
| Abbott Laboratories | $17.28 | 2023 | Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunit Singhal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.